Related Experiment Video
Updated: May 5, 2026
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
8.4K
Mesenchymal to epithelial transition in sarcomas.
Jilong Yang1, Xiaoling Du2, Guowen Wang3
1Department of Bone and Soft Tissue Tumors, National Clinical Cancer Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
European Journal of Cancer (Oxford, England : 1990)
|December 3, 2013
Summary
Mesenchymal to epithelial transition (MET) is crucial in sarcoma development and progression. Understanding MET in sarcomas may reveal new biomarkers and therapeutic targets for these challenging tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Mesenchymal to epithelial transition (MET) is implicated in carcinoma metastasis.
- MET is recognized as a significant biological and clinical factor in mesenchymal tumors, specifically sarcomas.
Purpose of the Study:
- To review existing research on MET in sarcomas.
- To explore molecular markers, signaling pathways, microRNA regulation, and therapeutic strategies related to MET in sarcomas.
Main Methods:
- Literature review of studies on MET in sarcomas.
- Analysis of molecular markers and signaling mechanisms.
- Investigation of microRNA involvement.
- Examination of therapeutic implications.
Main Results:
- MET plays a role in sarcoma pathogenesis.
- Specific molecular markers and signaling pathways are associated with MET in sarcomas.
- MicroRNAs are involved in regulating MET in sarcomas.
- MET presents potential therapeutic targets and prognostic biomarkers.
Conclusions:
- Further research into MET in sarcomas is essential.
- Understanding MET can illuminate sarcoma pathogenesis.
- MET could lead to novel clinical biomarkers and therapeutic targets for sarcomas.
Related Concept Videos
02:30Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
01:19Cadherins in Tissue Organization
3.5K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.5K
01:19Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
70
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
70
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:19Cell Migration
6.1K
Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
6.1K